Development and validation of a multiparameter prognostic model for extranodal natural killer/T-cell lymphoma: Integration of clinical, pathological, and molecular biomarkers
Volume 23 | Continuous 2026
We value your privacy
We use necessary cookies to run this website. With your consent, we may also use analytics, preference, functional, and marketing cookies.